Metabolic surgery reduces CRC disease progression through circulating bile acid diversion
Science Translational Medicine · 2025
DOI: 10.1126/scitranslmed.ads9705 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, 2025. Verfasst von Claudia Lässle und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of General and Visceral Surgery, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany. Hauptthemen laut MEDLINE: Bile Acids and Salts, Colorectal Neoplasms, Disease Progression. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Obesity is a global epidemic characterized by energy disequilibrium, metabolic disorders, and fat mass development that greatly affect the health status of individuals. There is evidence that the intake of a high-fat diet and overweight are associated with the incidence of colorectal cancer (CRC). Metabolic surgery has been associated with improvements in obesity-related comorbidities and a reduction in the overall cancer risk. However, the underlying mechanism by which metabolic surgery reduces the risk of CRC remains unknown. To understand the antitumoral mechanism of bariatric surgery, we analyzed the development of CRC after Roux-en-Y gastric bypass (RYGB) surgery in an RYGB-CRC mouse model. Here, we showed that RYGB surgery substantially reduced primary tumorigenesis and prevented metastasis. This protective effect was mediated by bile acid (BA) exclusion from the proximal small intestine, leading to BA diversion in the preceding parts of the gastrointestinal tract and in circulation. The diverted BA profile in RYGB mice showed antitumoral and antimetastatic effects that were verified by BA exclusion of the proximal small bowel without the systemic metabolic installations of RYGB surgery by a cholecystointestinal shunt (CIS) surgery. RYGB surgery thus leads to reduced primary BAs and elevated secondary BAs in circulation. In a translational study involving patients with CRC with metachronous liver metastases, we confirmed that reduced primary BA concentrations in the serum were associated with prolonged time to metastasis, underscoring the critical role of BAs in CRC progression and metastatic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of General and Visceral Surgery, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
- EXCEL Excellent Clinician Scientist Program, Else Kroener Research School for Physicians at the Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
- German Cancer Consortium (DKTK) partner site Freiburg, 79106 Freiburg, Germany.
- German Cancer Research Center (DKFZ) Heidelberg, 69120 Heidelberg, Germany.
- IMM-PACT Clinician Scientist Program, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
ORCID-Profile: Claudia Lässle, Bernhard Mauerer, Lisa Marx, Reinhild Feuerstein, Luisa Schäfer, Gabriel Seifert, Goran Marjanovic, Ziwen Zheng, Philipp Holzner, Christopher Berlin, Rebecca Kesselring
Zitieren
APA
Lässle, C., Mauerer, B., Marx, L., Feuerstein, R., Braumüller, H., Broghammer, V., Schäfer, L., Enderle, C., Lünstedt, J., Seifert, G., Marjanovic, G., Zheng, Z., Holzner, P., Fichtner-Feigl, S., Berlin, C., & Kesselring, R. (2025). Metabolic surgery reduces CRC disease progression through circulating bile acid diversion. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.ads9705
Vancouver
Lässle C, Mauerer B, Marx L, Feuerstein R, Braumüller H, Broghammer V, et al. Metabolic surgery reduces CRC disease progression through circulating bile acid diversion. Science Translational Medicine. 2025. doi:10.1126/scitranslmed.ads9705
BibTeX
@article{Lssle2025,
author = {Lässle, Claudia and Mauerer, Bernhard and Marx, Lisa and Feuerstein, Reinhild and Braumüller, Heidi and Broghammer, Veit and Schäfer, Luisa and Enderle, Celine and Lünstedt, Jost and Seifert, Gabriel and Marjanovic, Goran and Zheng, Ziwen and Holzner, Philipp and Fichtner-Feigl, Stefan and Berlin, Christopher and Kesselring, Rebecca},
title = {Metabolic surgery reduces CRC disease progression through circulating bile acid diversion},
journal = {Science Translational Medicine},
year = {2025},
doi = {10.1126/scitranslmed.ads9705}
}
EUVIMED